Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Minia University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Allist Pharmaceuticals, Inc.
Sun Yat-sen University
Astellas Pharma Inc
Yale University
Hoffmann-La Roche
Institut Bergonié
National Cancer Institute (NCI)
Medical College of Wisconsin
BicycleTx Limited
National Institutes of Health Clinical Center (CC)
Institut du Cancer de Montpellier - Val d'Aurelle
Bayer
EXACT Therapeutics AS
Mayo Clinic
Psyence Australia Pty Ltd
Akeso
Eastern Cooperative Oncology Group
Massachusetts General Hospital
Hangzhou Converd Co., Ltd.
Jazz Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Centre Leon Berard
Ohio State University Comprehensive Cancer Center
Zhejiang University